DE69414502D1 - Medizinische Vorrichtung zur Verabreichung von Aktivsubstanzen oder Arzneistoffen in sehr niedriger Dosis, insbesondere von homöopatischen Arzneistoffen - Google Patents

Medizinische Vorrichtung zur Verabreichung von Aktivsubstanzen oder Arzneistoffen in sehr niedriger Dosis, insbesondere von homöopatischen Arzneistoffen

Info

Publication number
DE69414502D1
DE69414502D1 DE69414502T DE69414502T DE69414502D1 DE 69414502 D1 DE69414502 D1 DE 69414502D1 DE 69414502 T DE69414502 T DE 69414502T DE 69414502 T DE69414502 T DE 69414502T DE 69414502 D1 DE69414502 D1 DE 69414502D1
Authority
DE
Germany
Prior art keywords
drugs
administration
medical device
low doses
active substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69414502T
Other languages
English (en)
Other versions
DE69414502T2 (de
Inventor
Paolo Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Avantgarde SpA
Original Assignee
Avantgarde SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantgarde SpA filed Critical Avantgarde SpA
Publication of DE69414502D1 publication Critical patent/DE69414502D1/de
Application granted granted Critical
Publication of DE69414502T2 publication Critical patent/DE69414502T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69414502T 1993-09-02 1994-08-02 Medizinische Vorrichtung zur Verabreichung von Aktivsubstanzen oder Arzneistoffen in sehr niedriger Dosis, insbesondere von homöopatischen Arzneistoffen Expired - Fee Related DE69414502T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930591A IT1261849B (it) 1993-09-02 1993-09-02 Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.

Publications (2)

Publication Number Publication Date
DE69414502D1 true DE69414502D1 (de) 1998-12-17
DE69414502T2 DE69414502T2 (de) 1999-04-08

Family

ID=11401933

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69414502T Expired - Fee Related DE69414502T2 (de) 1993-09-02 1994-08-02 Medizinische Vorrichtung zur Verabreichung von Aktivsubstanzen oder Arzneistoffen in sehr niedriger Dosis, insbesondere von homöopatischen Arzneistoffen

Country Status (12)

Country Link
US (1) US5683712A (de)
EP (1) EP0641561B1 (de)
JP (1) JPH07165566A (de)
KR (1) KR950007808A (de)
AT (1) ATE173162T1 (de)
CA (1) CA2129760A1 (de)
DE (1) DE69414502T2 (de)
DK (1) DK0641561T3 (de)
ES (1) ES2125380T3 (de)
GR (1) GR3029308T3 (de)
IT (1) IT1261849B (de)
ZA (1) ZA946698B (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475514B1 (en) * 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
GB2354636A (en) * 1999-09-25 2001-03-28 Ibm Mounting chips on substrates
FR2806910B1 (fr) * 2000-04-03 2003-01-24 Dolisos Lab Procede d'inactivation virale de solutions hydro-alcooliques
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
US20030022206A1 (en) * 2001-05-16 2003-01-30 Kay Robert A. Method of characterizing a homeopathic preparation
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76641C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
UA76639C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
UA76640C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб
US20050255139A1 (en) * 2004-05-14 2005-11-17 Hurd Jonathan L Polymeric compositions with embedded pesticidal desiccants
US20060188558A1 (en) * 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
CA2631927C (en) 2005-12-01 2015-08-18 University Of Massachusetts Lowell Botulinum nanoemulsions
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
EP2015773A4 (de) 2006-04-27 2010-05-05 Anterios Inc Prüfung der effekte topischer verabreichung chemisch denervierender pharmazeutika
KR20090024241A (ko) * 2006-06-06 2009-03-06 올레그 일리치 엡쉬테인 비만, 당뇨병 및 내당능 장애 관련 질병 치료용 약제
SG10201607909WA (en) 2006-12-01 2016-11-29 Anterios Inc Peptide nanoparticles and uses therefor
EP2494958A1 (de) 2006-12-01 2012-09-05 Anterios, Inc. Nanopartikel aus amphiphilen Einheiten
US8940326B2 (en) 2007-03-19 2015-01-27 Vita Sciences Llc Transdermal patch and method for delivery of vitamin B12
CN103961315A (zh) 2007-05-31 2014-08-06 安特里奥公司 核酸纳米粒子和其用途
US20090047334A1 (en) * 2007-08-13 2009-02-19 Patricia Williams Transdermal patch for extended delivery of calcium
WO2009158687A1 (en) 2008-06-26 2009-12-30 Anterios, Inc. Dermal delivery
WO2012007845A2 (en) 2010-07-15 2012-01-19 Oleg Iliich Epshtein A method of increasing the effect of an activated-potentiated form of an antibody
JP2013532182A (ja) 2010-07-15 2013-08-15 イリイチ・エプシテイン オレグ 組み合わせ医薬組成物及び神経変性疾患に関連する疾患又は状態を治療する方法
EP2593138A2 (de) 2010-07-15 2013-05-22 Oleg Iliich Epshtein Pharmazeutische kombinationszusammensetzung und verfahren zur behandlung von funktionserkrankungen oder leiden des magen-darm-trakts
KR101906132B1 (ko) 2010-07-17 2018-10-10 메르크 파텐트 게엠베하 침투 및 작용의 증진
BR112013001297A2 (pt) 2010-07-21 2017-11-21 Oleg Iliich Epshtein composições farmacêuticas e respectivo uso e método de tratamento de doença ou condição respiratória
CA2805963A1 (en) 2010-07-21 2012-01-26 Oleg Iliich Epshtein A method of treating attention deficit hyperactivity disorder
CN103596559A (zh) 2011-01-24 2014-02-19 安特里奥公司 纳米颗粒组合物、其制剂和它们的用途
US20120328549A1 (en) 2011-01-24 2012-12-27 Anterios, Inc. Oil compositions
EP2667854B1 (de) 2011-01-24 2019-01-16 Anterios, Inc. Nanopartikelzusammensetzungen
AU2012223195A1 (en) * 2011-03-03 2013-10-17 Nancy Josephine Polich Homeopathic therapeutic method and compositions
US10022335B2 (en) 2011-03-03 2018-07-17 Nancy Josephine Polich Homeopathic therapeutic method and compositions
AU2012225367B2 (en) 2011-03-10 2017-05-25 Rigel Pharmaceuticals, Inc. 2,4 substituted pyrimidinediamines for use in discoid lupus
WO2012129519A1 (en) 2011-03-23 2012-09-27 Deseret Biologicals, Inc. Formulations of diluted amino acid segments and methods for making same
BE1020027A3 (fr) 2011-06-23 2013-04-02 Jean Pierre Mageren Compositions homeopathiques pour le traitement des douleurs du dos et des sciatiques.
US9597385B2 (en) 2012-04-23 2017-03-21 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
KR101365321B1 (ko) * 2012-05-22 2014-02-20 제일약품주식회사 매트릭스내 비스테로이드성 소염진통제의 농도구배를 이용하여 경피투과도를 향상시킨 패취제
EP2895172B1 (de) 2012-09-12 2019-02-06 Rigel Pharmaceuticals, Inc. Vitiligo-behandlung
MX2015013894A (es) 2013-04-03 2015-12-11 Allertein Therapeutics Llc Composiciones de nanoparticulas novedosas.
EP3137082A4 (de) 2014-05-01 2018-02-28 Anterios, Inc. Verfahren zur behandlung, vorbeugung und verbesserung von hauterkrankungen
AU2016300199B2 (en) 2015-07-24 2019-01-03 Glaxo Group Limited Treatment for vitiligo
BR112019010131A2 (pt) 2016-11-21 2019-10-08 Eirion Therapeutics Inc entrega transdérmica de agentes grandes
JP2021508453A (ja) 2017-12-20 2021-03-11 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ ボツリヌス毒素細胞結合ドメインポリペプチドおよび皮膚の若返りのための使用方法
AU2019338459A1 (en) 2018-09-13 2021-04-08 Eirion Therapeutics, Inc. Plasminogen activator inhibitor 1 (PAI-1) inhibitors and uses therefor
WO2020056191A1 (en) 2018-09-13 2020-03-19 Eirion Therapeutics, Inc. Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors
MX2021006102A (es) 2018-12-03 2021-09-21 Eirion Therapeutics Inc Suministro mejorado de agentes grandes.
EP3969038A1 (de) 2019-05-14 2022-03-23 Eirion Therapeutics, Inc. Verzögerung der spitzenwirkung und/oder verlängerung der dauer der reaktion

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060084A (en) * 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4605548A (en) * 1983-05-31 1986-08-12 Nitto Electric Industrial Co., Ltd. Drug administration material
US4788064A (en) * 1987-07-31 1988-11-29 Warner-Lambert Company Transdermal delivery system
WO1992006701A1 (en) * 1990-10-18 1992-04-30 Huffstutler, M., Conrad, Jr. Preparation of concentrated fluid symphytum extracts, therapeutic forms and methods of use

Also Published As

Publication number Publication date
JPH07165566A (ja) 1995-06-27
ITRM930591A1 (it) 1995-03-02
DE69414502T2 (de) 1999-04-08
KR950007808A (ko) 1995-04-15
US5683712A (en) 1997-11-04
ITRM930591A0 (it) 1993-09-02
ATE173162T1 (de) 1998-11-15
GR3029308T3 (en) 1999-05-28
CA2129760A1 (en) 1995-03-03
EP0641561B1 (de) 1998-11-11
EP0641561A3 (de) 1995-09-27
ZA946698B (en) 1995-05-02
ES2125380T3 (es) 1999-03-01
DK0641561T3 (da) 1999-07-26
IT1261849B (it) 1996-06-03
EP0641561A2 (de) 1995-03-08

Similar Documents

Publication Publication Date Title
DE69414502D1 (de) Medizinische Vorrichtung zur Verabreichung von Aktivsubstanzen oder Arzneistoffen in sehr niedriger Dosis, insbesondere von homöopatischen Arzneistoffen
DE3685895D1 (de) Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
ATE188866T1 (de) Transdermales arzneimittelverabreichungssystem
DE3879853D1 (de) Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien.
ES2062093T3 (es) Emplasto de varias capas.
KR900701274A (ko) 남용 가능성을 감소시킨 용량 제형
DE3669828D1 (de) Mittel und vorrichtung zur steuerung der transdermalen penetration topischer und systematischer wirkstoffe.
DE3766308D1 (de) Kombination von carbidopa/levodopa mit verzoegerter wirkstoffabgabe.
ATE361073T1 (de) Neue formulierungen zur transdermalen verabreichung von pergolid
KR900015761A (ko) 경피성 단일체 시스템
DK567088A (da) Indretning til transdermal laegemiddelindgift
ATE238778T1 (de) Transdermales therapeutisches system zur abgabe von hormonen
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
KR900013993A (ko) 활성물질의 국소 또는 계통적 투여를 위한 단계적 약물 방출을 나타내는 경피 시스템 및 그 용도
ATE89756T1 (de) Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen.
EP0235259A4 (de) Transdermale arzneimitteleinzeldosis gegen angina und verfahren zu ihrer verabreichung.
DE59603246D1 (de) Flächenstabilisierte pharmazeutische zubereitung zur anwendung auf der haut

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee